Finisar (FNSR) Tops Q2 EPS by 2c, Guides Q3 EPS Below Consensus at Mid-Point

Finisar (NASDAQ: FNSR) reported Q2 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $321.1 million versus the consensus estimate of $313.86 million.

GUIDANCE:

Finisar sees Q3 2016 EPS of $0.19-$0.25, versus the consensus of $0.24. Finisar sees Q3 2016 revenue of $300-320 million, versus the consensus of $318.62 million.

For earnings history and earnings-related data on Finisar (FNSR) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c